Displaying 16 (all) recruiting clinical trials.
-
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Response and Biology-Based Risk factor-guided therapy in treating younger patients with non-high Neuroblastoma
This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor ...
-
HEAD START 4: NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS
If your child has been diagnosed with medulloblastoma or other central nervous system embryonal tumors, your child may qualify to participate in a study. The ...
-
Camp High 5 2016: Evaluation of the Effect on Upper Limb Function
This study is looking to determine the benefits of a program forcing use of your child's weaker arm/hand followed by bi manual training ... -
Correlation of clinical response of children with short stature to growth hormone therapy and composition of the gut microbiome.
There are normally bacteria present in everyone's gut. The purpose of this study is to evaluate if the subjects with short stature have different ... -
WUH: A phase 3 long term open-label trial investigating safety and efficacy of Transcon hGH administered once weekly in children with growth hormone deficiency (GHD) who have completed a prior Transcon hGH trial.
This is a multicenter, phase 3, long-term, open-label extension trial of weekly TransCon hGH in children with Growth Hormone Deficiency (GHD) who previously participated in ... -
Understanding the Benefits of Cannabidiol in Children with Autism Spectrum Disorder
There is currently no pharmacological treatment for autism spectrum disorder (ASD), but research has shown that cannabidiol (CBD) might be helpful for improving social and ... -
REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects
The purpose of this study is to evaluate the safety and effectiveness (or how well the device works) of the LOTUS EdgeTM Valve System used ... -
NN8640-4245 - A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to daily Norditropin in children with short stature born small for gestational age with no catch-up growth by 2 years of age or older
This research study involves children born small and who stayed small. Treatment is somapacitan once a week compared to Norditropin® once a day. Researchers will ... -
A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin in children with growth hormone deficiency
Purpose of the research study is to collect information to help us understand how doctors treat and manage children and adolescent with growth hormone deficiency ... -
A Global Multicenter Open-label Matched Historical Control Study of Intrathecal SHP611 in Subjects with Late Infantile Metachromatic Leukodystrophy (MLD)
The purpose of this study is to evaluate the safety of the study drug and the effect of the study drug on motor function (the ...